LuX-Valve TTVR Device Provides Favorable 1-Year Results
Where this device will fit in with other emerging options remains to be seen, but it might hold an advantage in large annuli.
By Xiangbin Pan, MD, PhD | Apr 28, 2025
Plant-Derived Compound Shows Early Promise for Small AAAs
In aneurysms normally chosen for surveillance, the endovascular technique slowed growth by 70% in the small phase I trial.
By Andrew Holden, MBChB | Apr 28, 2025
Tags: CVD
Apr 04, 2025
Expert: Caitlin Cox, Yael Maxwell, Laura McKeown, Todd Neale, and Mike O'Riordan
OVERVIEW :
Hear the podcast from TCTMD covering the top stories in cardiology, latest in clinical education and an exploration...
How to Manage TAVR Valve Embolization
Tags: TAVR
Apr 28, 2025
By: James B Hermiller MD, MSCAI
OVERVIEW :
Access the live cases featuring new techniques and therapies, Case-based presentations with interactive discussion presented during scientific meetings...
Indications and Pre-Procedural Screening for ViV/ViR Procedures
Tags: valvular heart disease
Apr 29, 2025
Expert presentations include the latest clinical data, procedural guidance, advanced expertise, late breaking clinical trials and innovative approaches...
By: Anita W Asgar MD, MSc, FSCAI
Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK
The novel dissolvable therapy had a 93.2% probability of being cost-effective at ...
By Andrew Holden, MBChB | Apr 25, 2025
LuX-Valve TTVR Device Provides Favorable 1-Year Results
Where this device will fit in with other emerging options remains to ...
By Andrew Holden, MBChB | Apr 25, 2025
Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices
Limus-based devices, rather than being a substitute for paclitaxel as they were ...
By Andrew Holden, MBChB | Apr 24, 2025
Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE
Ten years after learning their polygenic risk score, patients had fewer events—perhaps ...
By Andrew Holden, MBChB | Apr 24, 2025
OPINION POLL